- 関
- chlorothiazide
WordNet
- a silvery soft waxy metallic element of the alkali metal group; occurs abundantly in natural compounds (especially in salt water); burns with a yellow flame and reacts violently in water; occurs in sea water and in the mineral halite (rock salt) (同)Na, atomic number 11
- a diuretic drug (trade name Diuril) used in the treatment of edema and hypertension (同)Diuril
PrepTutorEJDIC
- ソジウム,ナトリウム(金属元素;化学記号はNa)
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/05/04 10:29:28」(JST)
[Wiki en表示]
Chlorothiazide
|
|
Systematic (IUPAC) name |
6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide |
Clinical data |
Trade names |
Diuril |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a682341 |
Pregnancy
category
|
- US: C (Risk not ruled out)
|
Legal status
|
|
Routes of
administration
|
Oral, IV |
Pharmacokinetic data |
Bioavailability |
low |
Metabolism |
Nil |
Half-life |
45 to 60 hours |
Excretion |
Renal |
Identifiers |
CAS Registry Number
|
58-94-6 Y |
ATC code
|
C03AA04 |
PubChem |
CID 2720 |
DrugBank |
DB00880 Y |
ChemSpider |
2619 Y |
UNII |
77W477J15H Y |
KEGG |
D00519 Y |
ChEBI |
CHEBI:3640 Y |
ChEMBL |
CHEMBL842 Y |
Chemical data |
Formula |
C7H6ClN3O4S2 |
Molecular mass
|
295.72 g/mol |
SMILES
- O=S(=O)(c1c(Cl)cc2c(c1)S(=O)(=O)/N=C\N2)N
|
InChI
-
InChI=1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13) Y
Key:JBMKAUGHUNFTOL-UHFFFAOYSA-N Y
|
Y (what is this?) (verify) |
Chlorothiazide sodium (Diuril) is a diuretic used within the hospital setting or for personal use to manage excess fluid associated with congestive heart failure. It is also used as an antihypertensive.
Most often taken in pill form, it is usually taken orally once or twice a day. In the ICU setting, chlorothiazide is given to diurese a patient in addition to furosemide (Lasix). Working in a separate mechanism than furosemide, and absorbed enterically as a reconstituted suspension administered through a nasogastric tube (NG tube), the two drugs potentiate one another.
Contents
- 1 Indications
- 2 Contraindications
- 3 Dose
- 4 Side effects
- 5 History
Indications
- Large amount of excess fluid including:
- Diagnosed congested heart failure
- Peripheral edema
- Rales / Rhonchi
- Hypertension
Contraindications
- Renal failure or insufficiency
- Allergies to sulfa drugs
Dose
- 500 mg–1 g once or twice a day, by mouth or through NG tube (reconstituted suspension)
- May also be given intravenously, and should be given first if given in combination with IV lasix since it potentiate's the diuretic effect of furosemide.
Side effects
- Nausea / Vomiting
- Headache
- Dizziness
- Excess urine production
- Dehydration
- Hypoelectrolytemia (esp. hypokalemia / hypomagnesia)
History
The Research team of Merck Sharp and Dohme Research Laboratories: Karl H. Beyer, Jr., M.D., Ph.D.; James M. Sprague, Ph.D.; John E. Baer, Ph.D.; and Frederick C. Novello, Ph.D. created a new series of medications, the thiazide diuretics, which includes chlorothiazide. They won an Albert Lasker Special Award in 1975 for its creation. http://www.laskerfoundation.org/awards/formaward.htm
Symporter inhibitors
|
|
Sodium chloride |
- thiazide: Bendroflumethiazide
- Chlorothiazide
- Cyclopenthiazide
- Cyclothiazide
- Hydrochlorothiazide
- Hydroflumethiazide
- Methyclothiazide
- Polythiazide
- Trichlormethiazide
other: Chlorthalidone
- Metolazone
|
|
Sodium, potassium, chloride |
|
|
Antihypertensives: diuretics (C03)
|
|
Sulfonamides
(and etacrynic acid) |
CA inhibitors (at PT) |
|
|
Loop (Na-K-Cl at AL) |
- Furosemide#
- Bumetanide
- Etacrynic acid
- Etozoline
- Muzolimine
- Piretanide
- Tienilic acid
- Torasemide
|
|
Thiazides (Na-Cl at DCT,
Calcium-sparing) |
- Altizide
- Bendroflumethiazide
- Chlorothiazide
- Cyclopenthiazide
- Cyclothiazide
- Epithiazide
- Hydrochlorothiazide#
- Hydroflumethiazide
- Mebutizide
- Methyclothiazide
- Polythiazide
- Trichlormethiazide
|
|
Thiazide-likes (primarily DCT) |
- Quinethazone
- Clopamide
- Chlortalidone
- Mefruside
- Clofenamide
- Metolazone
- Meticrane
- Xipamide
- Indapamide
- Clorexolone
- Fenquizone
|
|
|
Potassium-sparing (at CD) |
ESC blockers |
- Amiloride#
- Triamterene
- Benzamil
|
|
Aldosterone antagonists |
- Spironolactone#
- Eplerenone
- Potassium canrenoate
- Canrenone
|
|
|
Osmotic diuretics (PT, DL) |
|
|
Vasopressin receptor antagonists
(DCT and CD) |
- vaptans: Conivaptan
- Mozavaptan
- Satavaptan
- Tolvaptan
- tetracyclines: Demeclocycline
|
|
Other |
- ethanol, isopropanol, 2M2B
- mercurial diuretic (Mersalyl, Meralluride)
- Theobromine
- Cicletanine
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Index of the circulatory system
|
|
Description |
- Anatomy
- Arteries
- head and neck
- arms
- chest
- abdomen
- legs
- Veins
- head and neck
- arms
- chest
- abdomen and pelvis
- legs
- Development
- Cells
- Physiology
|
|
Disease |
- Congenital
- Neoplasms and cancer
- Lymphatic vessels
- Injury
- Vasculitis
- Other
- Symptoms and signs
|
|
Treatment |
- Procedures
- Drugs
- beta blockers
- channel blockers
- diuretics
- nonsympatholytic vasodilatory antihypertensives
- peripheral vasodilators
- renin–angiotensin system
- sympatholytic antihypertensives
- vasoprotectives
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- FGF23 regulates renal sodium handling and blood pressure.
- Andrukhova O1, Slavic S1, Smorodchenko A1, Zeitz U1, Shalhoub V2, Lanske B3, Pohl EE1, Erben RG4.
- EMBO molecular medicine.EMBO Mol Med.2014 May 5;6(6):744-59. doi: 10.1002/emmm.201303716.
- Fibroblast growth factor-23 (FGF23) is a bone-derived hormone regulating renal phosphate reabsorption and vitamin D synthesis in renal proximal tubules. Here, we show that FGF23 directly regulates the membrane abundance of the Na(+):Cl(-) co-transporter NCC in distal renal tubules by a signaling mec
- PMID 24797667
- Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
- Sinke AP1, Kortenoeven ML, de Groot T, Baumgarten R, Devuyst O, Wetzels JF, Loffing J, Deen PM.
- American journal of physiology. Renal physiology.Am J Physiol Renal Physiol.2014 Mar 1;306(5):F525-33. doi: 10.1152/ajprenal.00617.2013. Epub 2013 Dec 18.
- Lithium is the most common cause of nephrogenic diabetes insipidus (Li-NDI). Hydrochlorothiazide (HCTZ) combined with amiloride is the mainstay treatment in Li-NDI. The paradoxical antidiuretic action of HCTZ in Li-NDI is generally attributed to increased sodium and water uptake in proximal tubules
- PMID 24352504
- Acute inhibition of NCC does not activate distal electrogenic Na+ reabsorption or kaliuresis.
- Hunter RW1, Craigie E, Homer NZ, Mullins JJ, Bailey MA.
- American journal of physiology. Renal physiology.Am J Physiol Renal Physiol.2014 Feb 15;306(4):F457-67. doi: 10.1152/ajprenal.00339.2013. Epub 2014 Jan 8.
- Na(+) reabsorption from the distal renal tubule involves electroneutral and electrogenic pathways, with the latter promoting K(+) excretion. The relative activities of these two pathways are tightly controlled, participating in the minute-to-minute regulation of systemic K(+) balance. The pathways a
- PMID 24402096
Japanese Journal
- Traxanox Sodiumの健常人における利尿作用および尿酸排せつ作用 反復投与試験によるHydrochlorothiazideとの比較:反復投与試験によるHydrochlorothiazideとの比較
- 実験的糸球体腎炎ラットにおける尿中Prostaglandin Eの排泄について
- Cortisolの近位尿細管におけるNa転送促進作用のActinomycin Dによる抑制について
★リンクテーブル★
[★]
- 英
- chlorothiazide sodium
- 関
- クロロチアジド
[★]
- 日
- 関
- 関
- Thiazide diuretic s
- 同
- Diuril
- 同
- Diuril
- 関
- Thiazide diuretic s